drugset / Trial / NCT02903407

Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU

NCT02903407 ↗

Phase 4 Terminated 7 enrolled Duke University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to examine the use of protocol directed sedation using the Duke PAD protocol with the current sedation medications of propofol or dexmedetomidine compared to the PAD protocol with midazolam, per cardiac intensive care unit (CICU) usual care, as an initial step toward understanding the best management of sedation in these patients.

Timeline

Start
2017-09-01
Primary completion
2019-06-30
Completion
2019-06-30

Outcome

Outcome not reported

Stopped (Enrollment): “All enrolled participants completed the study protocol but the study was terminated prior to the goal number of participants due to low recruitment”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified — Intravenous
Comparator Midazolam Small molecule — Intravenous
Comparator Propofol Small molecule — Intravenous